Frontiers in Cell and Developmental Biology (Dec 2022)
Contribution of TEX15 genetic variants to the risk of developing severe non-obstructive oligozoospermia
- Andrea Guzmán-Jiménez,
- Andrea Guzmán-Jiménez,
- Sara González-Muñoz,
- Sara González-Muñoz,
- Miriam Cerván-Martín,
- Miriam Cerván-Martín,
- Rocío Rivera-Egea,
- Rocío Rivera-Egea,
- Nicolás Garrido,
- Nicolás Garrido,
- Saturnino Luján,
- Samuel Santos-Ribeiro,
- Samuel Santos-Ribeiro,
- José A. Castilla,
- José A. Castilla,
- José A. Castilla,
- M. Carmen Gonzalvo,
- M. Carmen Gonzalvo,
- Ana Clavero,
- Ana Clavero,
- F. Javier Vicente,
- F. Javier Vicente,
- Vicente Maldonado,
- Javier Villegas-Salmerón,
- Miguel Burgos,
- Rafael Jiménez,
- Maria Graça Pinto,
- Isabel Pereira,
- Joaquim Nunes,
- Josvany Sánchez-Curbelo,
- Olga López-Rodrigo,
- Iris Pereira-Caetano,
- Patricia Isabel Marques,
- Patricia Isabel Marques,
- Filipa Carvalho,
- Filipa Carvalho,
- Alberto Barros,
- Alberto Barros,
- Lluís Bassas,
- Susana Seixas,
- Susana Seixas,
- João Gonçalves,
- João Gonçalves,
- Alexandra M. Lopes,
- Alexandra M. Lopes,
- Sara Larriba,
- Rogelio J. Palomino-Morales,
- Rogelio J. Palomino-Morales,
- F. David Carmona,
- F. David Carmona,
- Lara Bossini-Castillo,
- Lara Bossini-Castillo,
- IVIRMA Group,
- Lisbon Clinical Group
Affiliations
- Andrea Guzmán-Jiménez
- Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain
- Andrea Guzmán-Jiménez
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- Sara González-Muñoz
- Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain
- Sara González-Muñoz
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- Miriam Cerván-Martín
- Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain
- Miriam Cerván-Martín
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- Rocío Rivera-Egea
- Andrology Laboratory and Sperm Bank, IVIRMA Valencia, Valencia, Spain
- Rocío Rivera-Egea
- IVI Foundation, Health Research Institute La Fe, Valencia, Spain
- Nicolás Garrido
- IVI Foundation, Health Research Institute La Fe, Valencia, Spain
- Nicolás Garrido
- Servicio de Urología. Hospital Universitari i Politecnic La Fe e Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain
- Saturnino Luján
- Servicio de Urología. Hospital Universitari i Politecnic La Fe e Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain
- Samuel Santos-Ribeiro
- IVI-RMA Lisbon, Lisbon, Portugal
- Samuel Santos-Ribeiro
- Department of Obstetrics and Gynecology, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
- José A. Castilla
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- José A. Castilla
- Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de Las Nieves, Granada, Spain
- José A. Castilla
- CEIFER Biobanco—GAMETIA, Granada, Spain
- M. Carmen Gonzalvo
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- M. Carmen Gonzalvo
- Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de Las Nieves, Granada, Spain
- Ana Clavero
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- Ana Clavero
- Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de Las Nieves, Granada, Spain
- F. Javier Vicente
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- F. Javier Vicente
- 0UGC de Urología, HU Virgen de las Nieves, Granada, Spain
- Vicente Maldonado
- 1UGC de Obstetricia y Ginecología, Complejo Hospitalario de Jaén, Jaén, Spain
- Javier Villegas-Salmerón
- Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain
- Miguel Burgos
- Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain
- Rafael Jiménez
- Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain
- Maria Graça Pinto
- 2Centro de Medicina Reprodutiva, Maternidade Alfredo da Costa, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal
- Isabel Pereira
- 3Departamento de Obstetrícia, Ginecologia e Medicina da Reprodução, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisboa, Portugal
- Joaquim Nunes
- 3Departamento de Obstetrícia, Ginecologia e Medicina da Reprodução, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisboa, Portugal
- Josvany Sánchez-Curbelo
- 4Laboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, Barcelona, Spain
- Olga López-Rodrigo
- 4Laboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, Barcelona, Spain
- Iris Pereira-Caetano
- 5Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal
- Patricia Isabel Marques
- 6i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- Patricia Isabel Marques
- 7Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
- Filipa Carvalho
- 6i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- Filipa Carvalho
- 8Serviço de Genética, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
- Alberto Barros
- 6i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- Alberto Barros
- 8Serviço de Genética, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
- Lluís Bassas
- 4Laboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, Barcelona, Spain
- Susana Seixas
- 6i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- Susana Seixas
- 7Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
- João Gonçalves
- 6i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- João Gonçalves
- 9ToxOmics—Centro de Toxicogenómica e Saúde Humana, Nova Medical School, Lisbon, Portugal
- Alexandra M. Lopes
- 6i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- Alexandra M. Lopes
- 0CGPP-IBMC—Centro de Genética Preditiva e Preventiva, Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal
- Sara Larriba
- 1Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
- Rogelio J. Palomino-Morales
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- Rogelio J. Palomino-Morales
- 2Departamento de Bioquímica y Biología Molecular I, Universidad de Granada, Granada, Spain
- F. David Carmona
- Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain
- F. David Carmona
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- Lara Bossini-Castillo
- Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain
- Lara Bossini-Castillo
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- IVIRMA Group
- Lisbon Clinical Group
- DOI
- https://doi.org/10.3389/fcell.2022.1089782
- Journal volume & issue
-
Vol. 10
Abstract
Background: Severe spermatogenic failure (SPGF) represents one of the most relevant causes of male infertility. This pathological condition can lead to extreme abnormalities in the seminal sperm count, such as severe oligozoospermia (SO) or non-obstructive azoospermia (NOA). Most cases of SPGF have an unknown aetiology, and it is known that this idiopathic form of male infertility represents a complex condition. In this study, we aimed to evaluate whether common genetic variation in TEX15, which encodes a key player in spermatogenesis, is involved in the susceptibility to idiopathic SPGF.Materials and Methods: We designed a genetic association study comprising a total of 727 SPGF cases (including 527 NOA and 200 SO) and 1,058 unaffected men from the Iberian Peninsula. Following a tagging strategy, three tag single-nucleotide polymorphisms (SNPs) of TEX15 (rs1362912, rs323342, and rs323346) were selected for genotyping using TaqMan probes. Case-control association tests were then performed by logistic regression models. In silico analyses were also carried out to shed light into the putative functional implications of the studied variants.Results: A significant increase in TEX15-rs1362912 minor allele frequency (MAF) was observed in the group of SO patients (MAF = 0.0842) compared to either the control cohort (MAF = 0.0468, OR = 1.90, p = 7.47E-03) or the NOA group (MAF = 0.0472, OR = 1.83, p = 1.23E-02). The genotype distribution of the SO population was also different from those of both control (p = 1.14E-02) and NOA groups (p = 4.33–02). The analysis of functional annotations of the human genome suggested that the effect of the SO-associated TEX15 variants is likely exerted by alteration of the binding affinity of crucial transcription factors for spermatogenesis.Conclusion: Our results suggest that common variation in TEX15 is involved in the genetic predisposition to SO, thus supporting the notion of idiopathic SPGF as a complex trait.
Keywords